Johnson & Johnson received unfavorable news for the company on Tuesday, June 1, after the Supreme Court rejected its appeal for the cancellation of a court decision where it was ordered to pay $2.1 billion in penalty.
The case against Johnson & Johnson is about the allegations the asbestos in its talc powder caused cancer in women, specifically many have reportedly developed ovarian cancer. The talc powder products also include the baby powder that has been around since 1893.
The Supreme Court upheld the penalty order
The high court announced without any kind of argument that it will not hear the case thus the penalty will not be scrapped. According to the order, Justices Samuel Alito and Brett Kavanaugh recused or disqualified themselves from consideration of the case.
CNBC reported that Johnson & Johnson made a request for the Supreme Court to assess the penalty it received after the amount was sustained by the Missouri Supreme Court in 2020. Although the amount is high, this was already reduced from the initial $4 billion.
The company that develops medical devices, pharmaceuticals and consumer packaged goods stated it is facing over 21,000 lawsuits for the talc products. Thus, in May 2020, Johnson & Johnson shared that it has already halted the selling of talc-based baby powder in Canada and the United States.
The company cited lower demand for the said item due to the spread of misinformation concerning the talc powders’ safety. It added the legal cases have also negatively affected the brand.
J&J’s response to the decision
In any case, J&J’s appeal for the Supreme Court to review its penalty was turned down and the opponent’s lawyer’s argument played a role. Ken Starr, a former Whitewater prosecutor who is representing the women who sued Johnson & Johnson, wrote in his brief that the justices should not review the case because, for decades, the company has been aware that their talc powders are made with asbestos as one of its ingredients. The substance is said to be “highly carcinogenic with no known safe exposure level.”
Finally, Reuters reported that J&J said the decision left unresolved legal issues and maintained that its baby powder is safe. The company reiterated there are scientific evaluations that prove the “product is safe, does not contain asbestos, and does not cause cancer."


SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates
Woodside Energy Denies Exxon Mobil Takeover Talks Amid LNG Growth Focus
German Auto Suppliers Turn Bearish as Investment and Jobs Shift Overseas
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business
China Industrial Output Beats Forecasts as Domestic Demand Weakens
Gold Holds Gains as Oil Prices Retreat and Fed Decision Looms
Roku Explores Sale Options as Interest Grows in Streaming and Ad Business
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns
BOJ Raises Interest Rates to 31-Year High, Signals Strong Focus on Inflation Risks
Myanmar Economic Outlook Hit by Fuel Price Shock as World Bank Cuts Growth Forecast
DOJ Clears Paramount Skydance-Warner Bros. Discovery Merger Without Conditions
Dollar Slips as U.S.-Iran Peace Deal Optimism Boosts Risk Appetite Ahead of Fed Decision
U.S.-Iran Peace Deal Extends Gulf Ceasefire, Reopens Strait of Hormuz 



